IL6 and obesity disorder: Whereas several pro-inflammatory cytokines, particularly IL-6, have been strongly associated with the development of M1 phenotypes of ATMs [25], myeloid cell IL-6 signaling can elicit the alternative activation of anti-inflammatory macrophages that limits the development of insulin resistance during obesity [29].